AI imaging tool to help diagnose prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests an AI computer tool that analyzes prostate scans to help tell if someone may have prostate cancer. It may help improve how doctors interpret imaging results and decide on next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be worried for prostate cancer after a clinic visit (high PSA blood test and/or an abnormal rectal exam)
- Be age 60 or older
- Have not had treatment for prostate cancer before (no surgery, radiation, or prostate-cancer medicines)
- If you’ve had procedures for non-cancer urinary blockage, that may be okay
- You must have a complete multiparametric MRI (mp-MRI) scan with clear images (not incomplete or distorted)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to better predict and treat prostate cancer. If you have a suspected prostate cancer diagnosis, your information may help improve AI-based care.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This study compares how artificial intelligence and doctors interpret prostate MRI scans to improve cancer detection and guide treatment decisions. You'll have an MRI scan and possibly a biopsy to help researchers understand which approach works best.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This trial studies how AI might improve the process of prostate biopsies for people who have had an MRI. It may help if you are scheduled for a biopsy and have not been treated for prostate cancer before.
Hear when a new the Application of Artificial Intelligence in the Diagnosis of Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.